On this page
What each program costs in North Dakota
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 11 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 12 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 13 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 14 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 15 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 16 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 17 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the NDPERS group health plan cover GLP-1s for weight loss?
North Dakota's NDPERS says GLP-1s are only available for the treatment of diabetes, not for weight loss, per its 2026 health insurance RFP answers and its October 2025 board materials.
North Dakota Public Employees Retirement System
In its 2026 health insurance RFP question-and-answer document, NDPERS says GLP-1s are only available to treat diabetes.
“Does the NDPERS currently cover GLP1s for weight loss? GLP-1s are only available for the treatment of diabetes.”
https://www.ndpers.nd.gov/sites/default/files/documents/about/rfp-bid-opportunities/health-rfp-2026-qna-responses.pdf · read Oct 29, 2026
North Dakota Public Employees Retirement System
The October 14, 2025 board book states the same while limiting diabetes GLP-1 fills to a 30-day supply.
“NDPERS does not cover GLP1 medication for weight loss”
https://www.ndpers.nd.gov/sites/www/files/documents/about/board/board-book-october-14-2025.pdf · read Oct 29, 2026
What do North Dakota's big insurers publish on Wegovy and Zepbound?
Blue Cross Blue Shield of North Dakota
Blue Cross Blue Shield of North Dakota removed weight-loss drug coverage, GLP-1s included, from fully insured non-grandfathered large group plans starting January 1, 2026 at plan anniversary. Self-funded employers choose whether to include these drugs.
Blue Cross Blue Shield of North Dakota
BCBSND's August 7, 2025 announcement removes weight-loss drug coverage from fully insured non-grandfathered large group plans starting January 1, 2026 at plan anniversary.
“Fully Insured Non-Grandfathered Large Group Plans: Coverage for weight-loss drugs, including GLP-1s and oral medications, will be removed.”
https://www.bcbsnd.com/newscenter/news/2026-weight-loss-drug-changes · read Oct 29, 2026
Blue Cross Blue Shield of North Dakota
Under the same change, self-funded employers decide whether their plan includes these drugs.
“Self-Funded Plans: Clients will need to choose to include these weight-loss drugs with their plan.”
https://www.bcbsnd.com/newscenter/news/2026-weight-loss-drug-changes · read Oct 29, 2026
Does North Dakota Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
North Dakota Medicaid names phentermine, bupropion, naltrexone and topiramate as its covered weight-loss agents, and its Wegovy and Zepbound criteria are for other conditions, so it does not cover Wegovy or Zepbound for weight loss alone. Read from state documents Nov 6, 2026.
What North Dakota Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. North Dakota Department of Health and Human Services, Medical Services Division.
WegovyNo
Criteria cover reduction of major heart events, with age and BMI rules, and MASH.
“The following drugs are covered without prior authorization by submitting a corresponding diagnosis code for the indication: o phentermine, bupropion, naltrexone, topiramate”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
“Agents covered for weight loss are phentermine, bupropion, naltrexone, and topiramate.”
North Dakota Health and Human Services, Medical Services Division · No effective date on the document · read Nov 6, 2026
“Mounjaro injection or Wegovy tablets: The member must have failed a 12-month trial of semaglutide injection, as evidenced by paid claims or pharmacy printouts.”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
ZepboundNo
Criteria cover moderate to severe obstructive sleep apnea with obesity and a failed CPAP trial. Zepbound is non-preferred.
“The following drugs are covered without prior authorization by submitting a corresponding diagnosis code for the indication: o phentermine, bupropion, naltrexone, topiramate”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
“Agents covered for weight loss are phentermine, bupropion, naltrexone, and topiramate.”
North Dakota Health and Human Services, Medical Services Division · No effective date on the document · read Nov 6, 2026
“The member must have a diagnosis of moderate to severe OSA defined as apnea-hypopnea index (AHI) > 15 determined by in-lab attended sleep study or polysomnography (PSG)”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
OzempicUnclear
The Weight Loss section of the coverage manual covers Ozempic injection for antipsychotic-induced weight gain, but its Obesity list does not name Ozempic. So it is not covered as a general obesity drug on these documents, yet a weight-related path exists for that one diagnosis.
“Ozempic injection and Victoza (brand) are covered without prior authorization by submitting diagnosis code T43.505A, T43.505D, or T43.505S if being used for antipsychotic-induced weight gain”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
“The following drugs are covered without prior authorization by submitting a corresponding diagnosis code for the indication: o phentermine, bupropion, naltrexone, topiramate”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
MounjaroNo
Mounjaro is listed for reduction of major heart events as non-preferred, after a failed semaglutide trial. It is not on the obesity list.
“The following drugs are covered without prior authorization by submitting a corresponding diagnosis code for the indication: o phentermine, bupropion, naltrexone, topiramate”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
“Agents covered for weight loss are phentermine, bupropion, naltrexone, and topiramate.”
North Dakota Health and Human Services, Medical Services Division · No effective date on the document · read Nov 6, 2026
“Mounjaro injection or Wegovy tablets: The member must have failed a 12-month trial of semaglutide injection, as evidenced by paid claims or pharmacy printouts.”
North Dakota Health and Human Services, Medical Services Division · Effective Oct 1, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from North Dakota Department of Health and Human Services, Medical Services Division documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
0 prescriptions
Ozempic and Mounjaro, 2025
1,683 prescriptions
Neighbours covering weight loss
1 of 3
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your North Dakota Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed North Dakota Medicaid as "not covered" for GLP-1s for obesity under fee-for-service. North Dakota Medicaid covers one or more older weight-loss drugs, but no GLP-1.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether North Dakota Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does North Dakota Medicaid pay for?
5,852 GLP-1 prescriptions in 2025, 50th of the 50 states and DC, with $3.6 million reimbursed before rebates. Counting the share other payers covered, $3.6 million.
Prescriptions, 2025
5,852
50th of 51
Medicaid paid
$3.6M
50th of 51, before rebates
Per prescription
$614
$1,051 nationally
Weight-loss brands
0.0%
51st highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. North Dakota is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.0% of North Dakota Medicaid's GLP-1 prescriptions in 2025 (0). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Liraglutide (generic) was North Dakota Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Liraglutide (generic) | 2,815 | 48% | $1.1 million | $376 |
| Ozempic | 1,616 | 28% | $1.6 million | $970 |
| Victoza | 1,343 | 23% | $882,757 | $657 |
| Mounjaro | 67 | 1.1% | $70,880 | $1,058 |
| Rybelsus | 11 | 0.2% | $10,763 | $978 |
| Wegovyapproved for weight management | 0 | 0.0% | $0 | n/a |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in North Dakota?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
North Dakota and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 3 states next to North Dakota covers GLP-1s for weight loss through Medicaid: Minnesota. None has a lower cash floor than North Dakota's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| North Dakota | Not covered | 17 | $39/mo |
| Minnesota | Covered | 19 | $39/moWellmedr |
| Montana | Not covered | 19 | $39/moWellmedr |
| South Dakota | Not covered | 19 | $39/moWellmedr |




















